Author
Naoya Kato
Also Known As
Kato N., Kato, Naoya, N KATO, N Kato, N. Kato, NAOYA KATO, Naoya KATO, Naoya Kato
207
Publications
3.7K
Citations
23
H-Index
87
Concepts
All Affiliations
| # | Concept | H-Index | Publications | Citations |
|---|---|---|---|---|
1 | Medicine | 12 | 13 | 2.2K |
2 | Engineering | 6 | 6 | 138 |
3 | Health Sciences | 2 | 2 | 466 |
4 | Natural Sciences | 2 | 2 | 1.3K |
5 | Social Sciences | 1 | 1 | 27 |
Naoya Kato
×
40
Publications
3.4K
Citations
22
H-Index
| Year | Citations | |
|---|---|---|
2012 | 1.3K | |
2020 | 438 | |
2024 | 254 | |
2003 | 168 | |
1990 | 157 | |
Durvalumab with or without bevacizumab with transarterial chemoembolisation in hepatocellular carcinoma (EMERALD-1): a multiregional, randomised, double-blind, placebo-controlled, phase 3 study Bruno Sangro, Masatoshi Kudo, Joseph P. Erinjeri, HepatologyTransarterial ChemoembolisationMedicinePharmacologyPathology | 2025 | 151 |
2022 | 113 | |
2017 | 75 | |
1997 | 52 | |
2011 | 38 |
Page 1
Page 1